12.1 Nanomaterials for Drug Delivery and Therapeutics
2 min read•july 25, 2024
are revolutionizing drug delivery, offering advantages like enhanced , , and controlled release. These tiny particles can protect drugs, reduce side effects, and even cross biological barriers, making them game-changers in medicine.
Safety concerns and challenges exist, including and immune system interactions. However, the potential of nanomaterials in therapeutics is vast, from to gene delivery and regenerative medicine. These innovations could transform how we treat diseases.
Nanomaterials in Drug Delivery
Advantages of nanomaterials in drug delivery
Top images from around the web for Advantages of nanomaterials in drug delivery
Frontiers | Editorial: Supramolecular Nanomaterials for Engineering, Drug Delivery, and Medical ... View original
Is this image relevant?
Frontiers | Research progress of Astaxanthin nano-based drug delivery system: Applications ... View original
Is this image relevant?
Frontiers | Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical ... View original
Is this image relevant?
Frontiers | Editorial: Supramolecular Nanomaterials for Engineering, Drug Delivery, and Medical ... View original
Is this image relevant?
Frontiers | Research progress of Astaxanthin nano-based drug delivery system: Applications ... View original
Is this image relevant?
1 of 3
Top images from around the web for Advantages of nanomaterials in drug delivery
Frontiers | Editorial: Supramolecular Nanomaterials for Engineering, Drug Delivery, and Medical ... View original
Is this image relevant?
Frontiers | Research progress of Astaxanthin nano-based drug delivery system: Applications ... View original
Is this image relevant?
Frontiers | Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical ... View original
Is this image relevant?
Frontiers | Editorial: Supramolecular Nanomaterials for Engineering, Drug Delivery, and Medical ... View original
Is this image relevant?
Frontiers | Research progress of Astaxanthin nano-based drug delivery system: Applications ... View original
Is this image relevant?
1 of 3
- Enhanced drug solubility and increases -to-volume ratio improves dissolution rates (, )
- Targeted delivery to specific tissues or cells uses through enhanced permeability and retention effect and with surface modifications (antibodies, peptides)
- Controlled release of drugs sustains release over time or triggers release in response to stimuli (pH, temperature)
- Protection of drugs from degradation encapsulates in nanocarriers (, polymeric nanoparticles)
- Reduced side effects lowers systemic exposure to drugs (doxorubicin-loaded nanoparticles)
- Ability to cross biological barriers penetrates blood-brain barrier (transferrin-modified nanoparticles)
- Multifunctional capabilities combine therapeutic and diagnostic functions ( for and drug delivery)
Mechanisms of nanocarrier drug release
- drives drug release through concentration gradient ()
- breaks down nanocarrier materials via hydrolysis or enzymatic action ()
- triggers by pH, temperature, enzymes, or light ()
- uses hydrogel-based nanocarriers ()
- detaches drug from nanocarrier surface ()
Safety and Applications
Challenges of nanomaterial drug delivery
- Toxicity concerns accumulate in organs and affect cellular functions long-term (liver, spleen)
- Immune system interactions risk immunogenicity and activate complement system ()
- Stability and shelf life cause aggregation of nanoparticles and affect chemical stability of drugs and carriers
- Scalability and manufacturing challenges impact reproducibility of nanocarrier properties and cost-effective production
- involve complex approval processes and lack standardized testing protocols
- and clearance lead to potential off-target accumulation and affect renal and hepatic clearance mechanisms
Potential of nanomaterials in therapeutics
- Cancer therapy applications enhance tumor targeting through , enable combination therapy, and facilitate photothermal and photodynamic therapies (, )
- delivers DNA and RNA using nanocarriers and CRISPR-Cas9 systems ()
- develop nanoparticle-based antibiotics and wound healing dressings ()
- treat across blood-brain barrier for Alzheimer's and Parkinson's disease ()
- target atherosclerotic plaques and use nanoparticle-based contrast agents for imaging (iron oxide nanoparticles)
- Regenerative medicine creates nanostructured scaffolds for tissue engineering and delivers growth factors and stem cells ()
Key Terms to Review (39)
Active targeting: Active targeting refers to the strategic design and utilization of nanomaterials that are engineered to specifically interact with and bind to particular cells or tissues in the body. This method enhances the effectiveness of drug delivery systems by ensuring that therapeutic agents are delivered precisely where they are needed, minimizing side effects and improving patient outcomes. The focus on active targeting allows for a more tailored approach to treatment, which is crucial in areas such as cancer therapy where traditional methods may not be as effective.
Antimicrobial applications: Antimicrobial applications refer to the use of substances that kill or inhibit the growth of microorganisms, such as bacteria, viruses, and fungi. These applications are particularly significant in nanotechnology, where nanomaterials are utilized for their unique properties to enhance the effectiveness of antimicrobial agents, thereby improving drug delivery systems and therapeutic interventions.
Bioavailability: Bioavailability refers to the proportion of a drug or therapeutic agent that enters the systemic circulation when it is introduced into the body and is available for action at the intended site. This concept is crucial in understanding how effectively a treatment can work, as it determines how much of the administered substance actually reaches its target, especially in the context of nanomaterials designed for drug delivery. In addition, bioavailability plays a significant role in assessing the potential health impacts of these materials, as variations in absorption can influence both therapeutic efficacy and toxicity.
Biodistribution: Biodistribution refers to the study of how substances, such as drugs or nanomaterials, are distributed throughout the body after administration. This involves understanding where these substances accumulate, how long they stay in different organs or tissues, and how they are ultimately eliminated. In the context of drug delivery and therapeutics, biodistribution is crucial for evaluating the efficacy and safety of therapeutic agents, particularly nanomaterials designed to improve targeted delivery and reduce side effects.
Cancer therapy: Cancer therapy refers to the various treatments used to combat cancer, which may include surgery, radiation, chemotherapy, immunotherapy, and targeted therapies. In the context of nanotechnology, cancer therapy has been revolutionized through the use of nanomaterials that enhance drug delivery and improve therapeutic efficacy while minimizing side effects. These advancements allow for more precise targeting of cancer cells, improving treatment outcomes and patient quality of life.
Cardiovascular applications: Cardiovascular applications refer to the use of nanotechnology to develop innovative solutions for diagnosing, preventing, and treating heart and vascular diseases. This field utilizes nanomaterials to enhance drug delivery systems, improve imaging techniques, and create targeted therapies that can specifically address cardiovascular conditions, thereby improving patient outcomes and reducing side effects.
Chitosan nanoparticles: Chitosan nanoparticles are tiny particles derived from chitosan, a biopolymer obtained from chitin found in the shells of crustaceans. These nanoparticles are known for their biocompatibility, biodegradability, and ability to encapsulate drugs or other therapeutic agents, making them highly useful in various biomedical applications and environmental remediation processes.
Curcumin-loaded PLGA nanoparticles: Curcumin-loaded PLGA nanoparticles are nanoscale carriers made from poly(lactic-co-glycolic acid) (PLGA) that encapsulate curcumin, a bioactive compound derived from turmeric known for its anti-inflammatory and antioxidant properties. These nanoparticles enhance the solubility, stability, and bioavailability of curcumin, making them an innovative approach in drug delivery systems aimed at improving therapeutic outcomes.
Degradation-controlled release: Degradation-controlled release refers to a method of drug delivery where the release of therapeutic agents is regulated by the breakdown of the delivery system itself. This approach allows for a sustained and predictable release profile, often enhancing the effectiveness of the drug while minimizing side effects. By designing materials that degrade at specific rates, this method can be tailored to match the pharmacokinetics of the drug being delivered.
Desorption-based release: Desorption-based release refers to the process where molecules, such as drugs, detach from a carrier material, often nanomaterials, to be released into a target site in the body. This mechanism is crucial for controlled drug delivery systems, allowing for precise timing and dosage of therapeutic agents. By utilizing desorption, these systems can improve the effectiveness of treatments while minimizing side effects.
Diffusion-controlled release: Diffusion-controlled release is a mechanism through which drugs are delivered in a controlled manner, relying on the process of diffusion to regulate the rate at which a drug is released from its delivery system. This method is significant in drug delivery systems, particularly those involving nanomaterials, as it allows for the sustained release of therapeutic agents over time, enhancing their effectiveness while minimizing side effects. By utilizing diffusion as the primary mechanism, the design of drug delivery systems can be tailored to achieve desired release profiles based on various factors such as material properties and environmental conditions.
Electrospun nanofibers: Electrospun nanofibers are extremely fine fibers produced through the electrospinning process, where a polymer solution is subjected to a high-voltage electric field to create continuous strands with diameters ranging from nanometers to micrometers. These nanofibers have unique properties such as high surface area, porosity, and tunable mechanical strength, making them suitable for various applications, particularly in drug delivery and therapeutics. Their small size allows for enhanced interaction with biological systems, improving the efficacy of therapeutic agents.
EPR Effect: The EPR effect, or Enhanced Permeability and Retention effect, refers to the phenomenon where nanoparticles and macromolecules tend to accumulate in tumor tissue more than in normal tissues due to the unique characteristics of tumor vasculature. This effect is particularly significant in the context of drug delivery, as it allows for the preferential targeting of cancer cells while minimizing damage to healthy cells. The EPR effect is a key principle driving the development of nanomaterials that can improve the efficacy of therapeutic agents by enhancing their localization within tumors.
Gene therapy: Gene therapy is a medical technique that involves modifying or manipulating genes to treat or prevent diseases, particularly genetic disorders. This approach can involve inserting new genetic material into a patient's cells, repairing or replacing defective genes, or even silencing harmful genes. The use of nanotechnology in drug delivery systems and nanorobotics enhances the effectiveness and precision of gene therapy, allowing targeted treatment with minimal side effects.
Gold nanorods: Gold nanorods are elongated nanoparticles made of gold, typically ranging in size from 10 to 100 nanometers in length. Their unique shape and size lead to distinct optical properties, especially in their ability to absorb and scatter light, making them useful in various biomedical applications, particularly in drug delivery and therapeutics.
Iron oxide nanoparticles: Iron oxide nanoparticles are tiny particles made primarily of iron oxides, such as magnetite (Fe3O4) and hematite (Fe2O3), typically ranging from 1 to 100 nanometers in size. These nanoparticles have unique magnetic, optical, and catalytic properties that make them valuable in various applications, including drug delivery and environmental remediation.
Lipid nanoparticles: Lipid nanoparticles are small, spherical structures composed of lipids that encapsulate therapeutic agents, making them ideal for drug delivery systems. These nanoparticles enhance the stability and bioavailability of drugs while facilitating targeted delivery to specific cells or tissues, thus playing a crucial role in modern therapeutics.
Liposomes: Liposomes are small, spherical vesicles composed of phospholipid bilayers that can encapsulate drugs or other molecules, making them an important tool in nanotechnology. Their unique structure allows them to carry therapeutic agents directly to target cells, enhancing drug delivery and efficacy. This ability connects liposomes to the classification of nanomaterials and highlights their significance in developing advanced delivery systems for drugs and therapeutics.
Matrix systems: Matrix systems are structured materials designed to encapsulate and deliver therapeutic agents, often used in drug delivery applications. They play a critical role in controlling the release rate of drugs, improving bioavailability, and enhancing the overall efficacy of treatment. By manipulating the matrix's composition and structure, researchers can create targeted delivery mechanisms that optimize therapeutic outcomes.
Mesoporous silica nanoparticles: Mesoporous silica nanoparticles (MSNs) are nanostructured materials with a porous framework and pore sizes typically between 2 to 50 nanometers, making them highly suitable for various applications, especially in drug delivery and therapeutics. Their large surface area and tunable pore sizes allow for efficient loading of therapeutic agents, controlled release, and enhanced stability. This unique combination of properties positions MSNs as an attractive platform in nanomedicine, providing targeted delivery of drugs to specific cells or tissues.
MRI: MRI, or Magnetic Resonance Imaging, is a medical imaging technique that uses strong magnetic fields and radio waves to create detailed images of the organs and tissues inside the body. This technology is particularly useful in providing high-resolution images without the use of ionizing radiation, making it a preferred choice for various diagnostic applications, including assessing diseases and conditions affecting soft tissues.
Nanocrystals: Nanocrystals are tiny semiconductor or metallic particles typically ranging from 1 to 100 nanometers in size, exhibiting unique optical and electronic properties due to their small size and high surface-to-volume ratio. These properties make nanocrystals particularly valuable in applications such as drug delivery and therapeutics, where they can enhance the effectiveness of treatments and minimize side effects.
Nanoemulsions: Nanoemulsions are fine oil-in-water or water-in-oil emulsions with droplet sizes typically in the range of 20 to 200 nanometers. They offer improved stability and enhanced bioavailability of drugs, making them important in the field of drug delivery and therapeutics. Their small size allows for better penetration through biological barriers, which can lead to increased effectiveness in therapeutic applications.
Nanomaterials: Nanomaterials are materials that have structural features at the nanoscale, typically ranging from 1 to 100 nanometers. These materials exhibit unique physical and chemical properties due to their small size and high surface area, making them highly versatile for various applications across different fields, including electronics, medicine, and environmental science.
Nanospheres: Nanospheres are tiny spherical particles typically ranging from 1 to 100 nanometers in size, often made of materials like polymers, metals, or silica. They are significant in the field of nanotechnology due to their unique properties, such as a large surface area-to-volume ratio and the ability to encapsulate drugs, making them valuable for targeted drug delivery and therapeutic applications.
Neurological disorders: Neurological disorders are a broad category of conditions that affect the nervous system, including the brain, spinal cord, and peripheral nerves. These disorders can impact a person's ability to move, think, communicate, and interact with the world around them. They encompass a wide range of diseases, such as Alzheimer's, Parkinson's, epilepsy, and multiple sclerosis, which can significantly affect the quality of life and may require complex treatment approaches.
Passive Targeting: Passive targeting refers to a drug delivery mechanism that utilizes the natural properties of nanoparticles to enhance the accumulation of therapeutic agents at specific sites within the body, often tumors or inflamed tissues. This process exploits the unique characteristics of the tumor microenvironment, such as leaky blood vessels and poor lymphatic drainage, which allow nanoparticles to preferentially accumulate in these areas without the need for external guidance or modification.
Pegylated nanoparticles: Pegylated nanoparticles are nanocarriers that have polyethylene glycol (PEG) chains attached to their surface, which helps to enhance their stability and biocompatibility. This modification improves their circulation time in the bloodstream, reduces immune recognition, and can facilitate targeted delivery of drugs or therapeutic agents directly to specific cells or tissues.
PLGA Nanoparticles: PLGA nanoparticles are biodegradable and biocompatible carriers made from a copolymer of poly(lactic acid) (PLA) and poly(glycolic acid) (PGA), designed for drug delivery applications. They play a crucial role in targeted and controlled release of therapeutics, improving the bioavailability and efficacy of drugs while minimizing side effects.
Quantum Dots: Quantum dots are tiny semiconductor particles, typically ranging from 2 to 10 nanometers in size, that exhibit quantum mechanical properties. Their unique size allows them to confine electrons and holes in three dimensions, leading to quantized energy levels that give quantum dots their distinct optical and electronic properties, making them significant in various advanced technologies.
Regulatory hurdles: Regulatory hurdles refer to the various legal and administrative challenges that companies and researchers must overcome to bring new products or technologies to market. These challenges can slow down the innovation process, especially in fields like nanotechnology where safety, efficacy, and environmental impact must be thoroughly evaluated before approval.
Silver nanoparticles: Silver nanoparticles are tiny particles of silver that measure between 1 and 100 nanometers in size, known for their unique properties such as antimicrobial activity and electrical conductivity. These properties make them highly valuable in various applications, particularly in drug delivery and therapeutics, where they can enhance the effectiveness of treatments and reduce side effects.
Solubility: Solubility refers to the ability of a substance (the solute) to dissolve in a solvent, forming a homogeneous solution at a specific temperature and pressure. It is a critical property in various applications, especially in drug delivery, where the solubility of drugs can influence their effectiveness, bioavailability, and therapeutic outcomes. Understanding solubility helps in designing nanomaterials that can enhance drug solubility, leading to improved drug delivery systems and better therapeutic responses.
Stimuli-responsive release: Stimuli-responsive release refers to the controlled and targeted delivery of therapeutic agents, such as drugs, from nanomaterials in response to specific external stimuli like pH, temperature, light, or enzymatic activity. This method enhances the efficacy of drug delivery systems by ensuring that therapeutic agents are released at the desired location and time, minimizing side effects and improving treatment outcomes.
Surface area: Surface area refers to the total area that the surface of an object occupies. In the context of nanotechnology, it is particularly important because as materials are reduced to the nanoscale, their surface area to volume ratio increases dramatically. This property enhances reactivity and interaction with biological systems, which is crucial for applications like drug delivery and tissue engineering.
Swelling-controlled release: Swelling-controlled release refers to a mechanism in drug delivery systems where the release of a therapeutic agent is regulated by the swelling behavior of a polymeric material. This approach allows for a more predictable and sustained release profile, as the drug is gradually released from the swollen matrix, responding to changes in environmental conditions such as pH or temperature. By utilizing materials that swell upon exposure to certain stimuli, this method enhances the effectiveness of drug therapies and minimizes side effects.
Targeted delivery: Targeted delivery refers to the method of directing therapeutic agents, like drugs, to specific cells or tissues in the body to enhance their effectiveness while minimizing side effects. This approach is particularly significant in the field of drug delivery and therapeutics, as it allows for more precise treatment options, especially for conditions like cancer where healthy tissues are often affected by conventional therapies.
Thermo-sensitive liposomes: Thermo-sensitive liposomes are specialized drug delivery systems that release their therapeutic payload in response to temperature changes. These liposomes are designed to remain stable and intact at normal body temperatures but become permeable and release their contents when exposed to elevated temperatures, such as those achieved during hyperthermia treatment for cancer. This property allows for targeted delivery of drugs while minimizing side effects, making them an essential tool in nanotechnology for drug delivery and therapeutics.
Toxicity: Toxicity refers to the degree to which a substance can harm living organisms, and it is crucial for assessing the safety of materials, especially in the context of nanotechnology. Understanding toxicity is vital because nanomaterials can exhibit unique properties that differ significantly from their bulk counterparts, leading to potential adverse health effects. Evaluating the toxicity of materials like carbon nanostructures and nanomaterials used in drug delivery is essential for ensuring their safe application in various fields.